drugset / Trial / NCT04556370
Norepinephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With Preeclampsia.
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to investigate the suitable infusion dose of norepinephrine for prophylaxis against postspinal anesthesia hypotension in parturients with preeclampsia undergoing cesarean section.
Timeline
- Start
- 2021-11-16
- Primary completion
- 2023-06-06
- Completion
- 2023-06-06
Outcome
Met primary endpoint
paper incidence of maternal hypotension was reduced with different prophylactic infusion rates of norepinephrine (26.7%, 15.6%, and 6.7%) compared with normal saline (37.8%) PMID 38869701 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Norepinephrine | Other / unclassified | 0.025 ug/kg | — |
| Subject | Norepinephrine | Other / unclassified | 0.05 ug/kg | — |
| Subject | Norepinephrine | Other / unclassified | 0.075 ug/kg | — |
Indications
No indication recorded.